Rockwell Medical logo
Rockwell Medical RMTI
$ 1.12 -1.75%

Quarterly report 2025-Q2
added 08-14-2025

report update icon

Rockwell Medical Financial Statements 2011-2025 | RMTI

Annual Financial Statements Rockwell Medical

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

35.5 M 20.5 M 38.5 M 86.2 M 166 M 153 M 286 M 282 M 311 M 447 M 345 M 131 M 186 M

Shares

23.3 M 14.3 M 8.53 M 71.8 M 60.9 M 52.8 M 50.8 M 50.8 M 49.7 M 41.4 M 33 M 20.4 M 17.7 M

Historical Prices

1.52 1.43 4.51 11.1 26.8 24.9 64 72 113 113 115 88.5 93.2

Net Income

-8.44 M -18.7 M -32.7 M -30.9 M -34.1 M -32.1 M -25.9 M -19.8 M -14.4 M -21.3 M -48.8 M -54 M -21.4 M

Revenue

83.6 M 72.8 M 61.9 M 62.2 M 61.3 M 63.4 M 57.3 M 53.3 M 55.4 M 54.2 M 52.4 M 49.8 M 49 M

Cost of Revenue

74.9 M 68.7 M 64.4 M 59.5 M 58.5 M 65 M 53.6 M - - - - - -

Gross Profit

8.7 M 4.08 M -2.42 M 2.72 M 2.84 M -1.58 M 3.7 M 6.75 M 8.94 M 8.55 M 6.66 M 6.69 M 5.64 M

Operating Income

-6.67 M -16.8 M -30.3 M -28.4 M -34.5 M -32.4 M -25.9 M -20.2 M -15.1 M -17.6 M -47.1 M -54.3 M -21.7 M

Interest Expense

2.3 M 1.94 M 2.36 M 1.88 M 25 K 313 K 1.63 K - - -4.15 M -1.82 M -951 -1.84 K

EBITDA

-5.23 M -16.2 M -29.7 M -30.1 M -31.4 M -30.8 M -25.4 M -19.4 M -14.3 M -16.6 M -46.1 M -53.2 M -20.5 M

Operating Expenses

- - - 31.1 M 36.9 M 29.8 M 29.6 M 27 M 24 M 26.1 M 53.7 M 61 M 27.3 M

General and Administrative Expenses

12.1 M 15.6 M 15.3 M 16.2 M 21 M 23.1 M 23.3 M 21.1 M 19.1 M 18.3 M 14.3 M 12.7 M 9.52 M

All numbers in USD currency

Quarterly Income Statement Rockwell Medical

2025-Q2 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

34.3 M 34.1 M 31.6 M 30.5 M 29.3 M 29.1 M 27.5 M 18.5 M 18.4 M 12.2 M 18.5 M 11.6 M 8.54 M 8.54 M 8.53 M 8.52 M 8.51 M 93.6 M 71.8 M 69.4 M 67.5 M 65.4 M 63.8 B 58.2 M 57.1 M 57 M 51.3 M 51.3 M 51.3 M 51.8 M 51.3 M 51 M 50.7 M 51.5 M 50.7 M 50.7 M 50.7 M 51.5 M 50.2 M 50.1 M 49.7 M 50.3 M 40.4 M 40 M 39.8 M 40.1 M 39.3 M 31.2 M 21.2 M 21.5 M 20.7 M 20.6 M 19.4 M 18.7 M 17.9 M 17.6 M 18.7 M

Net Income

-1.49 M - 1.66 M 343 K -1.73 M - -1.87 M -3.3 M -1.75 M - -4.19 M -4.97 M -7.16 M - -7.58 M -8.4 M -7.75 M - -7.35 M -6.89 M -7.98 M - -7.86 M -10.3 M -8.68 M - -4.97 M -12.2 M -5.55 M -9.04 M -5.06 M -7.08 M -4.74 M -5.05 M -4.56 M -5.36 M -4.82 M -5.77 M -2.41 M -2.54 M -3.7 M -6.38 M -3.97 M -3.17 M -7.81 M -8.33 M -13.2 M -11.9 M -15.4 M -13.7 M -17.9 M -11.9 M -10.6 M -8.95 M -5.04 M -4.54 M -2.91 M

Revenue

16.1 M - 28.3 M 25.8 M 22.7 M - 23.8 M 18.1 M 19.7 M - 18.7 M 18.7 M 16.1 M - 16 M 15.1 M 15.5 M - 60 M 60 M 60 M - 15.4 M 14.8 M 15.6 M - 16.7 M 14.9 M 14.9 M - 14.6 M 13.2 M 14.6 M - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

13.6 M - 22.1 M 21.3 M 19.6 M - 21.6 M 17 M 17.1 M - 17.9 M 16.9 M 16.9 M - 16.3 M 15.4 M 15.1 M - 14.9 M 15 M 14.7 M - 15.4 M 14.1 M 14.5 M - 14.7 M 18.9 M 15.7 M - 13.6 M 11.7 M - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

2.5 M - 6.24 M 4.55 M 3.06 M - 2.2 M 1.03 M 2.6 M - 777 K 1.74 M -786 K - -329 K -262 K 401 K - 346 K 881 K 1.11 M - -17 K 733 K 1.01 M - 1.97 M -4.02 M -720 K -1.22 M 1.07 M 1.5 M 2.36 M 1.99 M 1.58 M 1.49 M 1.69 M 2.06 M 2.5 M 2.07 M 2.31 M 2.58 M 2.27 M 2.02 M 1.68 M 2.06 M 1.63 M 1.69 M 1.28 M 1.7 M 1.65 M 1.72 M 1.63 M 1.54 M 1.38 M 1.07 M 1.65 M

Operating Income

-1.35 M - 1.94 M 515 K -1.32 M - -1.74 M -2.96 M -1.43 M - -3.71 M -4.48 M -6.63 M - -6.97 M -7.82 M -7.18 M - -6.69 M -5.6 M -8.06 M - -7.94 M -10.4 M -8.81 M - -5 M -12.3 M -5.72 M -9.22 M -5.03 M -6.72 M -4.96 M -5.26 M -4.75 M -5.59 M -4.61 M -6.06 M -2.57 M -2.65 M -3.81 M -5.02 M -3.13 M -2.38 M -7.03 M -7.53 M -12.4 M -11.8 M -15.4 M -13.7 M -17.9 M -12 M -10.7 M -8.96 M -5.12 M -4.62 M -3 M

Interest Expense

-143 K - -272 K -172 K 431 K - -135 K -346 K 387 K - 476 K 485 K 540 K - 609 K 583 K 581 K - 666 K 521 K 102 K - 16 K - - - 28.9 K 66.1 K 169 K - - - - - - - - - - - - -1.55 M -892 K -858 K -854 K -872 K -858 K -92.2 K -75 -105 -137 -456 -253 -331 -408 -504 -601

EBITDA

-949 K - 2.34 M 915 K -779 K - -1.34 M -2.76 M -1.27 M - -3.61 M -4.38 M -6.49 M - -6.44 M -7.44 M -6.98 M - -6.08 M -5.2 M -7.85 M - -7.36 M -9.99 M -8.62 M - -4.53 M -12 M -5.59 M -9.22 M -4.64 M -6.46 M -4.83 M -5.26 M -4.17 M -5.19 M -4.41 M -6.06 M -1.96 M -2.25 M -3.61 M -5.02 M -2.36 M -1.88 M -6.77 M -7.53 M -11.6 M -11.3 M -15.1 M -13.7 M -17.1 M -11.4 M -10.4 M -8.96 M -4.19 M -3.96 M -2.67 M

General and Administrative Expenses

3.28 M - 3.58 M 3.45 M 3.78 M - 2.89 M 3.3 M 3.25 M - 3.25 M 4.78 M 3.82 M - 3.88 M 3.68 M 3.92 M - 3.62 M 2.87 M 5.27 M - 4.62 M 5.5 M 6.22 M - 6.04 M 5.53 M 3.12 M 5.87 M 4.79 M 6.54 M 6.1 M 6.05 M 5.07 M 5.01 M 4.99 M 6.09 M 3.83 M 3.84 M 5.33 M 5.92 M 4.1 M 4.21 M 4.09 M 3.8 M 3.39 M 3.24 M 3.92 M 3.64 M 3.33 M 2.82 M 2.9 M 2.63 M 2.27 M 2.37 M 2.25 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Rockwell Medical RMTI
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Rockwell Medical plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Drug manufacturers industry

Issuer Price % 24h Market Cap Country
Amryt Pharma plc Amryt Pharma plc
AMYT
$ 14.7 - $ 621 M britainBritain
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
$ 15.25 - $ 754 M usaUSA
PetIQ PetIQ
PETQ
$ 13.6 1.64 % $ 400 M usaUSA
Agile Therapeutics Agile Therapeutics
AGRX
$ 0.6 10.11 % $ 58.2 M usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
$ 0.173 -13.85 % $ 16.1 M usaUSA
Recro Pharma Recro Pharma
REPH
$ 1.4 -4.76 % $ 65.3 M usaUSA
Athenex Athenex
ATNX
$ 0.2 -23.39 % $ 1.76 M usaUSA
PLx Pharma PLx Pharma
PLXP
$ 0.09 -27.8 % $ 2.56 M usaUSA
Shineco, Inc. Shineco, Inc.
TYHT
$ 11.09 -3.90 % $ 97.2 M chinaChina
Organogenesis Holdings Organogenesis Holdings
ORGO
$ 4.19 -2.1 % $ 552 M usaUSA
Lannett Company Lannett Company
LCI
$ 0.66 1.15 % $ 7.11 M usaUSA
Calliditas Therapeutics AB (publ) Calliditas Therapeutics AB (publ)
CALT
$ 40.0 -0.1 % $ 2.03 B schwedenSchweden
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
$ 218.96 - $ 6.81 B britainBritain
ProPhase Labs ProPhase Labs
PRPH
$ 0.39 2.61 % $ 6.18 M usaUSA
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
$ 8.22 - $ 376 M usaUSA
Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Limited
RDY
$ 14.6 0.9 % $ 2.42 B indiaIndia
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
$ 9.12 - $ 459 M usaUSA
SCYNEXIS SCYNEXIS
SCYX
$ 0.72 -5.05 % $ 34.5 M usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
$ 4.5 1.35 % $ 17.8 M chinaChina
Kindred Biosciences, Inc. Kindred Biosciences, Inc.
KIN
$ 9.25 0.11 % $ 419 M usaUSA
Sanofi Sanofi
SNY
$ 51.06 -0.68 % $ 66.8 B franceFrance
Supernus Pharmaceuticals Supernus Pharmaceuticals
SUPN
$ 53.17 0.85 % $ 2.93 B usaUSA
Neos Therapeutics, Inc. Neos Therapeutics, Inc.
NEOS
$ 1.15 -2.54 % $ 57.2 M usaUSA
Endo International plc Endo International plc
ENDP
$ 0.29 - $ 28.9 M irlandaIrlanda
Tricida Tricida
TCDA
$ 0.11 - $ 3.25 M usaUSA
Tilray Tilray
TLRY
$ 1.38 -6.12 % $ 853 M canadaCanada
PPD, Inc. PPD, Inc.
PPD
$ 47.25 0.13 % $ 16.6 B usaUSA
Bausch Health Companies Bausch Health Companies
BHC
$ 6.19 -0.24 % $ 2.26 B canadaCanada
HEXO Corp. HEXO Corp.
HEXO
$ 0.71 2.45 % $ 38.1 M -
Veru Veru
VERU
$ 3.65 -3.95 % $ 492 M usaUSA
Neptune Wellness Solutions Neptune Wellness Solutions
NEPT
$ 0.2 -45.3 % $ 917 K canadaCanada
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.
TARO
$ 42.97 - $ 1.62 B israelIsrael
Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company
HZNP
$ 116.3 - $ 26.6 B irlandaIrlanda
Viatris Viatris
VTRS
$ 10.29 -1.25 % $ 12.5 B usaUSA
FSD Pharma FSD Pharma
HUGE
$ 5.84 5743.5 % $ 69.7 M canadaCanada
Adamis Pharmaceuticals Corporation Adamis Pharmaceuticals Corporation
ADMP
$ 0.78 0.86 % $ 117 M usaUSA
Zynerba Pharmaceuticals Zynerba Pharmaceuticals
ZYNE
$ 1.3 - $ 55.5 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
$ 3.25 -0.31 % $ 3.64 M usaUSA
Alimera Sciences Alimera Sciences
ALIM
$ 5.54 - $ 142 M usaUSA
Biogen Biogen
BIIB
$ 149.13 -0.86 % $ 21.7 B usaUSA
Qilian International Holding Group Limited Qilian International Holding Group Limited
QLI
$ 5.41 -6.08 % $ 184 M chinaChina
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
$ 5.91 2.6 % $ 892 M -
Ironwood Pharmaceuticals Ironwood Pharmaceuticals
IRWD
$ 1.54 -5.52 % $ 245 M usaUSA
Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc
AVDL
$ 18.59 0.16 % $ 1.77 B franceFrance
Perrigo Company plc Perrigo Company plc
PRGO
$ 21.6 -1.55 % $ 2.97 B usaUSA
Cumberland Pharmaceuticals Cumberland Pharmaceuticals
CPIX
$ 3.3 3.45 % $ 46.4 M usaUSA
Aurora Cannabis Aurora Cannabis
ACB
$ 5.01 -1.57 % $ 86.3 M -
Eagle Pharmaceuticals Eagle Pharmaceuticals
EGRX
$ 2.14 -39.89 % $ 27.7 M usaUSA
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
$ 1.32 4.76 % $ 1.88 M chinaChina
OrganiGram Holdings OrganiGram Holdings
OGI
$ 1.64 -4.09 % $ 402 M canadaCanada